Table 2.
List of vaccines under clinical trials in India
| Formulation | Vaccine name | Company | Status |
|---|---|---|---|
| Protein subunit | Nuvaxovid | Novavax |
Approved in 40 countries, 22 trials in 14 countries |
| Corbevax | Biological E limited |
Approved in 2 countries, 7 trials in 1 country |
|
| Covovax (Novavax formulation) | Serum Institute of India |
Approved in 6 countries, 7 trials in 3 countries |
|
| AKS- 452 | University Medical center Groningen | 4 trials in 2 countries | |
| BECOV2B, BECOV2C, BECOV2D | Biological E limited | 2 trials in 1 country | |
| DNA | ZyCov-D | Zydus Cadila |
Approved in 1 country, 6 trials in 1 country |
| RNA | GEMCOVAC-19 | Gennova Biopharmaceutical Limited |
Approved in 1 country, 2 trials in 1 country |
| HGCO19 | Gennova Biopharmaceutical Limited | 2 trials in 1 country | |
| Inactivated virus | Covaxin | Bharat Biotech |
Approved in 14 countries, 16 trials in 2 countries |
| Non-replicating viral vector | INCOVACC | Bharat Biotech |
Approved in 1 country, 4 trials in 1 country |
| Sputnik Light | Gamaleya |
Approved in 26 countries, 7 trials in 3 countries |
|
| Sputnik V | Gamaleya |
Approved in 74 countries, 25 trials in 8 countries |
|
| Vaxzevria | Oxford/AstraZeneca |
Approved in 149 countries, 77 trials in 33 countries |
|
| Covishield (Oxford/AstraZeneca formulation) | Serum Institute of India |
Approved in 149 countries, 6 trials in 1 country |